Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients’ blood, research from the University of Michigan and the University of Kansas suggests.
Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with no effective treatments. Now, researchers at University of California San Diego School of Medicine have harnessed bioinformatics to fast-track the discovery of a promising new drug for SCI.
Deep brain stimulation (DBS) is a surgical procedure that entails the delivery of high-frequency electrical impulses to specific regions of the brain, via surgically implanted electrodes.
The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.
Findings point to promising drug that restores neuron balance and may slow disease progression
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
FastWave Medical today announced new first-in-human and pre-clinical data for its Sola coronary laser intravascular lithotripsy (L-IVL) system.
REDMOND, Wash., Oct. 28, 2025 /PRNewswire/ — Perimetrics, Inc., a dental technology company pioneering quantitative diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for the InnerView® System — the first FDA-cleared technology designed to measure both internal and external mobility in teeth and implants.
In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that contain features of good candidates for a vaccine.